{"ORPHApacket":[{"ORPHApacketID":"35889","date":"2019-12-05 17:34:58","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"35889","Name":[{"lang":"en","label":"Acute opioid poisoning"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_35889","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare disorder due to poisoning"}],"ORPHA":"556508","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_556508"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare intoxication with opioids, a large group of alkaloid analgesics, mainly characterized by miosis (pinpoint pupil), respiratory depression (bradypnea\/apnea) and central nervous system depression (sedation or coma). Other manifestations include hypotension, reduced bowel motility, hypothermia and hypoglycemia. Naloxone, a competitive inhibitor of the mu-opioid receptor, is a potent antagonist and is used as the antidote for opioid intoxication."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}]}]}